GlycoMimetics Inc (NASDAQ:GLYC)

16.66
Delayed Data
As of Apr 25
 -0.12 / -0.72%
Today’s Change
3.82
Today|||52-Week Range
26.05
-0.77%
Year-to-Date
No recent news for GlycoMimetics Inc.

Today’s Trading

Previous close16.78
Today’s open16.73
Day’s range16.11 - 16.95
Volume361,448
Average volume (3 months)805,907
Market cap$612.6M
Data as of 4:00pm ET, 04/25/2018

Growth & Valuation

Earnings growth (last year)+24.67%
Earnings growth (this year)+58.41%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book5.12

Competitors

 Today’s
change
Today’s
% change
AVEOAveo Pharmaceuticals...+0.03+1.16%
SVASinovac Biotech Ltd-0.01-0.13%
CRBPCorbus Pharmaceutica...-0.05-0.79%
DEPODepomed Inc-0.16-2.34%
Data as of 4:00pm ET, 04/25/2018

Financials

Next reporting dateMay 9, 2018
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$0.00
Annual profit (last year)-$33.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Rachel K. King
CFO, Secretary &
Principal Accounting Officer
Brian M. Hahn
Corporate headquarters
Rockville, Maryland

Forecasts